Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Roy Doumani


  • Director at Kite Pharma Inc. (KITE), 2017-10-06
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
KITE $84.53 5,000 Director 150,017 2017-06-08 Filing
KITE $84.46 10,000 Director 155,017 2017-06-07 Filing
KITE $76.77 2,800 Director 25,065 2017-03-01 Filing
KITE $77.03 6,000 Director 115,017 2017-03-01 Filing
KITE $72.27 10,000 Director 121,017 2017-03-01 Filing